The Epstein-Barr Virus LMP1 Interactome: Biological Implications and Therapeutic Targets

Overview

Journal Future Virol

Specialty Microbiology

Date 2021 Jun 3

PMID 34079586

Citations 6

Authors

Mujeeb R Cheerathodi

David G Meckes Jr

Affiliations

Soon will be listed here.

Abstract

The oncogenic potential of Epstein-Barr virus (EBV) is mostly attributed to latent membrane protein 1 (LMP1), which is essential and sufficient for transformation of fibroblast and primary lymphocytes. LMP1 expression results in the activation of multiple signaling cascades like NF-ΚB and MAP kinases that trigger cell survival and proliferative pathways. LMP1 specific signaling events are mediated through the recruitment of a number of interacting proteins to various signaling domains. Based on these properties, LMP1 is an attractive target to develop effective therapeutics to treat EBV-related malignancies. In this review, we focus on LMP1 interacting proteins, associated signaling events, and potential targets that could be exploited for therapeutic strategies.

Citing Articles

Inhibition of the Integrated stress response by Epstein-Barr virus oncoprotein LMP1 attenuates epithelial cell differentiation and lytic viral reactivation.

Singh D, Zhang Y, White S, Nelson S, Fogarty S, Pawelski A PLoS Pathog. 2025; 21(2):e1012934.

PMID: 39951426 PMC: 11828382. DOI: 10.1371/journal.ppat.1012934.

The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.

Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P Viruses. 2025; 16(12.

PMID: 39772235 PMC: 11680331. DOI: 10.3390/v16121928.

Epstein‑Barr virus as a promoter of tumorigenesis in the tumor microenvironment of breast cancer (Review).

Gomez-Archila J, Arellano-Galindo J, Palacios-Reyes C, Espinosa-Garcia A, Garcia Alonso-Themann P, Xicohtencatl-Cortes J Int J Mol Med. 2023; 52(2).

PMID: 37417334 PMC: 10373119. DOI: 10.3892/ijmm.2023.5275.

EBV-associated diseases: Current therapeutics and emerging technologies.

Chakravorty S, Afzali B, Kazemian M Front Immunol. 2022; 13:1059133.

PMID: 36389670 PMC: 9647127. DOI: 10.3389/fimmu.2022.1059133.

Mono a Mano: ZBP1's Love-Hate Relationship with the Kissing Virus.

Herbert A, Fedorov A, Poptsova M Int J Mol Sci. 2022; 23(6).

PMID: 35328502 PMC: 8955656. DOI: 10.3390/ijms23063079.

References

Zhou H, Guo W, Long C, Wang H, Wang J, Sun X . Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1. Biochem Biophys Res Commun. 2014; 456(3):815-20. DOI: 10.1016/j.bbrc.2014.12.023. View

Liu X, Li Y, Peng S, Yu X, Li W, Shi F . Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination. Cell Death Dis. 2018; 9(2):53. PMC: 5833833. DOI: 10.1038/s41419-017-0081-9. View

Xie P . TRAF molecules in cell signaling and in human diseases. J Mol Signal. 2013; 8(1):7. PMC: 3697994. DOI: 10.1186/1750-2187-8-7. View

Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S . Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res. 2000; 254(1):14-24. DOI: 10.1006/excr.1999.4733. View

Eliopoulos A, Young L . LMP1 structure and signal transduction. Semin Cancer Biol. 2001; 11(6):435-44. DOI: 10.1006/scbi.2001.0410. View

Sandberg M, Hammerschmidt W, Sugden B . Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol. 1997; 71(6):4649-56. PMC: 191686. DOI: 10.1128/JVI.71.6.4649-4656.1997. View

Everly Jr D, Mainou B, Raab-Traub N . Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol. 2004; 78(24):13470-8. PMC: 533955. DOI: 10.1128/JVI.78.24.13470-13478.2004. View

Miller W, Cheshire J, Raab-Traub N . Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression. Mol Cell Biol. 1998; 18(5):2835-44. PMC: 110662. DOI: 10.1128/MCB.18.5.2835. View

Ansieau S, Leutz A . The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif. J Biol Chem. 2001; 277(7):4906-10. DOI: 10.1074/jbc.M110078200. View

10.

Ai M, Li L, Zhao X, Wu Y, Gong J, Cao Y . Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res. 2005; 15(10):777-84. DOI: 10.1038/sj.cr.7290347. View

11.

Kim J, Jun S, Song M, Kim J, Song Y . The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines. Food Chem Toxicol. 2012; 50(5):1524-8. DOI: 10.1016/j.fct.2012.02.034. View

12.

Barile L, Vassalli G . Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017; 174:63-78. DOI: 10.1016/j.pharmthera.2017.02.020. View

13.

Kang S, Lim S, Song Y . Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activation. PLoS One. 2013; 8(11):e82688. PMC: 3841202. DOI: 10.1371/journal.pone.0082688. View

14.

Hadweh P, Habelhah H, Kieff E, Mosialos G, Hatzivassiliou E . The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation. Cell Signal. 2014; 26(12):2730-7. DOI: 10.1016/j.cellsig.2014.08.001. View

15.

Epstein M, Morgan A, Finerty S, Randle B, Kirkwood J . Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature. 1985; 318(6043):287-9. DOI: 10.1038/318287a0. View

16.

Bobrie A, Krumeich S, Reyal F, Recchi C, Moita L, Seabra M . Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012; 72(19):4920-30. DOI: 10.1158/0008-5472.CAN-12-0925. View

17.

Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E . An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol Cell Biol. 1987; 7(7):2299-308. PMC: 365360. DOI: 10.1128/mcb.7.7.2299-2308.1987. View

18.

Zhang D, Mao Y, Cao Q, Xiong L, Wen J, Chen R . Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display. Viruses. 2013; 5(4):1131-42. PMC: 3705269. DOI: 10.3390/v5041131. View

19.

Wilson J, WEINBERG W, Johnson R, Yuspa S, Levine A . Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell. 1990; 61(7):1315-27. DOI: 10.1016/0092-8674(90)90695-b. View

20.

Sprenger R, Fontijn R, van Marle J, Pannekoek H, Horrevoets A . Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. Biochem J. 2006; 400(3):401-10. PMC: 1698592. DOI: 10.1042/BJ20060355. View